Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Concept Videos

Mechanistic Models: Overview of Compartment Models01:21

Mechanistic Models: Overview of Compartment Models

320
Mechanistic models, a category encompassing both physiological and compartmental modeling, differ from empirical models' approaches to incorporating known factors about the systems being modeled. Empirical models describe data with minimal assumptions, while mechanistic models aim to provide a robust description of available data by specifying assumptions and integrating known factors about the system. Compartmental analysis is a key example of a mechanistic model in pharmacokinetics and...
320
Compartment Models: Single-Compartment Model01:14

Compartment Models: Single-Compartment Model

3.0K
The single-compartment model serves as a simplified representation of the human body. This model assumes that the body functions as a single, well-mixed open compartment. When a drug is administered intravenously, it enters the body and quickly distributes uniformly. The drug then undergoes biotransformation and elimination, ultimately leaving the body. The volume of this compartment is referred to as the apparent volume of distribution into which the drug can uniformly distribute. In this...
3.0K
Pharmacokinetic Models: Comparison and Selection Criterion01:26

Pharmacokinetic Models: Comparison and Selection Criterion

293
Physiological and compartmental models are valuable tools used in studying biological systems. These models rely on differential equations to maintain mass balance within the system, ensuring an accurate representation of the dynamic processes at play.
Physiological models take a detailed approach by considering specific molecular processes. They can predict drug distribution, metabolism, and elimination changes, providing a comprehensive understanding of how drugs interact with the body.
293
Clearance Models: Compartment Models01:25

Clearance Models: Compartment Models

279
Clearance measures drug elimination from the central compartment, including plasma and highly perfused organs like kidneys and liver. Its calculation varies depending on pharmacokinetic models and administration routes. The one-compartment model, for instance, portrays the pharmacokinetics of polar drugs such as aminoglycoside antibiotics administered intravenously and readily excreted in urine. In this case, clearance is influenced by the terminal rate constant (λz) and the total volume...
279
Model Approaches for Pharmacokinetic Data: Compartment Models01:14

Model Approaches for Pharmacokinetic Data: Compartment Models

491
Compartmental analysis is a widely adopted approach to characterizing drug pharmacokinetics. It uses compartment models that conceptualize the body as a collection of reversibly communicating compartments, each representing a group of tissues exhibiting similar drug distribution characteristics. The movement rate of the drug between these compartments is typically described by first-order kinetics.
Two primary types of compartment models are recognized: mammillary and catenary. The more...
491
Compartment Models: Two-Compartment Model01:20

Compartment Models: Two-Compartment Model

6.9K
The two-compartment model divides the body into central and peripheral compartments to account for varying blood perfusion rates among organs and tissues, affecting drug distribution. The central compartment includes blood and highly perfused tissues with rapid drug distribution, while the peripheral compartment contains tissues with slower drug distribution. After a single IV bolus dose, the drug concentration is high in plasma and low in tissues. The drug distribution between compartments...
6.9K

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

A nonstandard finite difference scheme for the SVICDR model to predict COVID-19 dynamics.

Mathematical biosciences and engineering : MBE·2022
Same author

Model for simulation of HIV/AIDS and cost-effectiveness of preventing non-tuberculous mycobacterial (MAC)-disease.

The European journal of health economics : HEPAC : health economics in prevention and care·2004
Same author

Economic evaluations of granulocyte colony-stimulating factor: in the prevention and treatment of chemotherapy-induced neutropenia.

PharmacoEconomics·2004
Same author

Cost-containment by early, rapid and precise detection of etiologic agents using modern molecular diagnostics?

International journal of medical microbiology : IJMM·2003

Related Experiment Video

Updated: Jan 4, 2026

Author Spotlight: Optimizing CFU Determination for Efficient Assessment of TB Vaccine Efficacy and Antigen Presentation Analysis
06:26

Author Spotlight: Optimizing CFU Determination for Efficient Assessment of TB Vaccine Efficacy and Antigen Presentation Analysis

Published on: July 28, 2023

2.9K

Compartment models for vaccine effectiveness and non-specific effects for Tuberculosis.

Sarah Treibert1, Helmut Brunner2,3, Matthias Xia Ehrhardt4

  • 1Albert-Ludwigs-Universität Freiburg, Ernst-Zermelo Strasse 1, 79104 Freiburg, Germany.

Mathematical Biosciences and Engineering : MBE
|November 9, 2019
PubMed
Summary

This study models tuberculosis (TB) epidemics, incorporating trained immunity and immigration factors to predict outbreak trajectories and vaccine effectiveness. The findings highlight necessary model upgrades for accurate forecasting of future TB outbreaks.

Keywords:
ODE systemSEIR modelTuberculosiscompartment modelsnon-specific effectstrained Immunityvaccination

More Related Videos

Enrichment of Native and Recombinant Extracellular Vesicles of Mycobacteria
06:38

Enrichment of Native and Recombinant Extracellular Vesicles of Mycobacteria

Published on: December 8, 2023

1.5K
Protective Efficacy and Pulmonary Immune Response Following Subcutaneous and Intranasal BCG Administration in Mice
06:32

Protective Efficacy and Pulmonary Immune Response Following Subcutaneous and Intranasal BCG Administration in Mice

Published on: September 19, 2016

10.9K

Related Experiment Videos

Last Updated: Jan 4, 2026

Author Spotlight: Optimizing CFU Determination for Efficient Assessment of TB Vaccine Efficacy and Antigen Presentation Analysis
06:26

Author Spotlight: Optimizing CFU Determination for Efficient Assessment of TB Vaccine Efficacy and Antigen Presentation Analysis

Published on: July 28, 2023

2.9K
Enrichment of Native and Recombinant Extracellular Vesicles of Mycobacteria
06:38

Enrichment of Native and Recombinant Extracellular Vesicles of Mycobacteria

Published on: December 8, 2023

1.5K
Protective Efficacy and Pulmonary Immune Response Following Subcutaneous and Intranasal BCG Administration in Mice
06:32

Protective Efficacy and Pulmonary Immune Response Following Subcutaneous and Intranasal BCG Administration in Mice

Published on: September 19, 2016

10.9K

Area of Science:

  • Epidemiology
  • Mathematical Biology
  • Immunology

Background:

  • Tuberculosis (TB) remains a global health challenge, necessitating accurate prediction models for emerging epidemics.
  • Factors like immigration from high-prevalence areas and trained immunity can influence TB transmission dynamics.

Purpose of the Study:

  • To develop a framework for model-specific predictions of new TB epidemics.
  • To incorporate the concept of trained immunity into epidemiological models.
  • To assess the impact of vaccination strategies under varying conditions.

Main Methods:

  • Utilized a mathematical approach with a system of ordinary differential equations.
  • Employed a SEIR-model (Susceptible-Exposed-Infectious-Recovered) adapted for TB.
  • Analyzed varying infection/attack rates and parameter settings.

Main Results:

  • Generated different disease progression graphs based on model parameters.
  • Demonstrated how vaccination effects vary with specific parameter and starting value configurations.
  • Identified key areas for model enhancement to improve predictive accuracy.

Conclusions:

  • The developed model provides insights into TB epidemic dynamics, including the role of trained immunity.
  • The study outlines necessary upgrades for a robust TB outbreak prediction system.
  • The model framework may also aid in predicting non-specific vaccine effects.